GNB Swiss Investments

Hani Salem, the founder, serves as Chairman and CEO of GNB Swiss Investments AG. He is the public face of the firm and appears to centralize investment decision-making given the firm's operating-company posture rather than a delegated committee structure.

The firm appears to source deals through corporate partnerships rather than traditional LP-to-GP channels. Its known co-investors include CRIF, a European credit-data and risk-analytics firm, and the Azimut Digitech Fund. This pattern suggests deal origination flows from business-information and corporate networks rather than from a blind-pool fund marketplace.

GNB Swiss Investments operates as an investment company with a generalist asset-manager classification. It does not publicly identify as a single-family office or multi-family office. The firm holds direct operating assets — pharmaceutical licenses, real estate developments, and a medicinal THC supply chain — which blurs the line between a pure allocator and an operating holding company.

Available evidence points to direct co-investment activity. The firm's known positions in BKN301 and Conio were executed alongside named co-investors (CRIF, Azimut Digitech Fund) rather than through fund-of-fund commitments. No public record indicates the firm operates as a limited partner in third-party blind-pool funds.

The firm's disclosed activity spans fintech (BKN301, Conio), urban and infrastructure real estate development, strategic and noble metals, medicinal THC supply chains across four continents, and pharmaceutical licensing in Switzerland and Russia. This wide mandate suggests no strict sector exclusions, though natural-resource and regulatory-adjacent industries feature prominently.

The firm maintains a business presence in Riyadh, Saudi Arabia, through GNB Malik LTD, which functions as its Middle East office. This entity likely serves as a booking and relationship hub for regional transactions, consistent with the firm's cross-border investment pattern linking Swiss corporate structures to MENA markets.

Chairman Hani Salem founded the Cannabis Business Club Zurich, a professional network that convened its 2022 conference. This industry association aligns with the firm's commercial interest in medicinal THC supply chains. No separate philanthropic foundation is disclosed in public records.